| Product Code: ETC8052262 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Lithuania saw an increase in subcutaneous drug delivery devices import shipments, with top exporters being China, Germany, USA, Netherlands, and Belgium. The market concentration shifted from low to moderate in 2024, indicating a more balanced distribution among suppliers. Despite a negative compound annual growth rate (CAGR) of -8.53% from 2020 to 2024, there was a slight growth uptick of 2.65% from 2023 to 2024. This suggests a potential turnaround in the market, with opportunities for further expansion and diversification in the subcutaneous drug delivery devices sector in Lithuania.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Lithuania Subcutaneous Drug Delivery Devices Market Overview |
3.1 Lithuania Country Macro Economic Indicators |
3.2 Lithuania Subcutaneous Drug Delivery Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Lithuania Subcutaneous Drug Delivery Devices Market - Industry Life Cycle |
3.4 Lithuania Subcutaneous Drug Delivery Devices Market - Porter's Five Forces |
3.5 Lithuania Subcutaneous Drug Delivery Devices Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Lithuania Subcutaneous Drug Delivery Devices Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Lithuania Subcutaneous Drug Delivery Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring long-term treatment that can benefit from subcutaneous drug delivery devices |
4.2.2 Growing demand for home-based healthcare solutions leading to higher adoption of subcutaneous drug delivery devices |
4.2.3 Technological advancements in subcutaneous drug delivery devices improving patient convenience and treatment outcomes |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval and commercialization of subcutaneous drug delivery devices |
4.3.2 Limited reimbursement policies for subcutaneous drug delivery devices impacting adoption rates |
4.3.3 High initial costs associated with acquiring and implementing subcutaneous drug delivery devices |
5 Lithuania Subcutaneous Drug Delivery Devices Market Trends |
6 Lithuania Subcutaneous Drug Delivery Devices Market, By Types |
6.1 Lithuania Subcutaneous Drug Delivery Devices Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Lithuania Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Lithuania Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Prefilled syringes, 2021- 2031F |
6.1.4 Lithuania Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Pen injectors, 2021- 2031F |
6.1.5 Lithuania Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Auto-injectors, 2021- 2031F |
6.1.6 Lithuania Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Wearable injectors, 2021- 2031F |
6.1.7 Lithuania Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Needle-free injectors, 2021- 2031F |
6.2 Lithuania Subcutaneous Drug Delivery Devices Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Lithuania Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Hospital pharmacies, 2021- 2031F |
6.2.3 Lithuania Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Retail pharmacies, 2021- 2031F |
6.2.4 Lithuania Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Online pharmacies, 2021- 2031F |
7 Lithuania Subcutaneous Drug Delivery Devices Market Import-Export Trade Statistics |
7.1 Lithuania Subcutaneous Drug Delivery Devices Market Export to Major Countries |
7.2 Lithuania Subcutaneous Drug Delivery Devices Market Imports from Major Countries |
8 Lithuania Subcutaneous Drug Delivery Devices Market Key Performance Indicators |
8.1 Patient adherence rate to subcutaneous drug delivery devices |
8.2 Number of healthcare facilities offering subcutaneous drug delivery devices as a treatment option |
8.3 Rate of adoption of subcutaneous drug delivery devices compared to traditional delivery methods |
9 Lithuania Subcutaneous Drug Delivery Devices Market - Opportunity Assessment |
9.1 Lithuania Subcutaneous Drug Delivery Devices Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Lithuania Subcutaneous Drug Delivery Devices Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Lithuania Subcutaneous Drug Delivery Devices Market - Competitive Landscape |
10.1 Lithuania Subcutaneous Drug Delivery Devices Market Revenue Share, By Companies, 2024 |
10.2 Lithuania Subcutaneous Drug Delivery Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |